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biocatalysis†
M. Teresa De Martino, a Fabio Tonin,b N. Amy Yewdall,a Mona Abdelghani,a
David S. Williams,‡a Ulf Hanefeld, b Floris P. J. T. Rutjes,c
Loai K. E. A. Abdelmohsen *a and Jan C. M. van Hest *a
Nano-sized enzyme aggregates, which preserve their catalytic activity are of great interest for ﬂow
processes, as these catalytic species show minimal diﬀusional issues, and are still sizeable enough to be
eﬀectively separated from the formed product. The realization of such catalysts is however far from
trivial. The stable formation of a micro-to millimeter-sized enzyme aggregate is feasible via the
formation of a cross-linked enzyme aggregate (CLEA); however, such a process leads to a rather broad
size distribution, which is not always compatible with microﬂow conditions. Here, we present the design
of a compartmentalized templated CLEA (c-CLEnA), inside the nano-cavity of bowl-shaped polymer
vesicles, coined stomatocytes. Due to the enzyme preorganization and concentration in the cavity,
cross-linking could be performed with substantially lower amount of cross-linking agents, which was
highly beneﬁcial for the residual enzyme activity. Our methodology is generally applicable, as
demonstrated by using two diﬀerent cross-linkers (glutaraldehyde and genipin). Moreover, c-CLEnA
nanoreactors were designed with Candida antarctica Lipase B (CalB) and Porcine Liver Esterase (PLE), as
well as a mixture of glucose oxidase (GOx) and horseradish peroxidase (HRP). Interestingly, when genipin
was used as cross-linker, all enzymes preserved their initial activity. Furthermore, as proof of principle,
we demonstrated the successful implementation of diﬀerent c-CLEnAs in a ﬂow reactor in which the c-
CLEnA nanoreactors retained their full catalytic function even after ten runs. Such a c-CLEnA
nanoreactor represents a signiﬁcant step forward in the area of in-ﬂow biocatalysis.Introduction
In recent years microreactor technology for continuous ow
catalysis has developed into an attractive alternative for tradi-
tional batch processes, because of the higher level of control
over mass and heat transfer.1–5 Reactions in-ow are further-
more scalable and oﬀer broader windows of operation and
automated optimization protocols.6,7 In case catalytic steps are
involved, heterogeneous catalysts are preferred from a process-
ing point of view, as they enable easy separation from the
product ow and allow catalyst recycling.8 Catalyststitute for Complex Molecular Systems
logy, Het Kranenveld 14, 5600 MB
.hest@tue.nl; l.k.e.a.abdemohsen@tue.nl
sity of Technology, Van der Maasweg 9,
dboud University, Heyendaalseweg 135,
tion (ESI) available. See DOI:
mistry, College of Science, Swansea
2 8PP, United Kingdom.
of Chemistry 2020immobilization however can also lead to some disadvantages,
such as diﬀusional limitations and problems associated with
catalyst leaching.9,10
The current implementation of enzymes in in-ow reactions
relies on their immobilization, which mostly involves binding
and/or physical adsorption to porous or solid supports (e.g.
resin or silica) or encapsulation in an inert carrier, aﬀording
a biocatalyst with acceptable performance in-ow.11,12 Indeed,
immobilization is advantageous in terms of reusability and
stability and is a well-established route for the commercial
application of enzyme-based catalysis.10 However, these tradi-
tional types of immobilization oen aﬀect enzyme perfor-
mance, provide limited physical protection and leaching
remains an important issue which limits the recyclability.13
Leaching can be limited via the formation of cross-linked
enzyme aggregates (CLEAs).14 CLEAs provide enhanced
stability, with the ability to be recaptured, recycled and reused
aer ltration or centrifugation processes.12 CLEAs have been
studied over the past decade as a green and facile route towards
industrial catalysis.10 However, due to their broad distribution
of size, such CLEAs are less well-dened regarding enzyme
display and are therefore less eﬀectively introduced inChem. Sci.
Chemical Science Edge Article
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View Article Onlinemicroow systems. In an ideal situation, catalytic systems can
operate freely in solution without diﬀusional barriers, and can still
be eﬀectively separated and recovered from the product ow. This
can for example be achieved by applying nanoreactors, nano-
particles functionalized with catalytic species that function as
homogeneous catalysts in a continuous ow system.15,16 In our
group we have much experience with employing copolymeric
vesicles or polymersomes, as functional nanoreactors due to their
ability to encapsulate enzymes.17–20 Over the past years we have
developed two diﬀerent strategies; we have constructed semi-
permeable vesicles in which the enzymes were encapsulated in
the lumen,21 andwe have created bowl-shaped polymersomes, also
known as stomatocytes, in which the enzymeswere engulfed in the
bowl, or stomach of the particles.22 In both cases the robust
polymermembrane provided protection againstmechanical forces
and enabled physical separation from undesired interactions with
other catalytic species. In the case of stomatocytes, diﬀusional
barriers are hardly present, as the stomach is in direct contact with
the reaction medium. However, the physical encapsulation of
enzymes inside the stomatocytes' cavity still poses a challenge; the
encapsulated enzymes are prone to leaching and the nanoreactors
are subsequently deactivated upon extended usage.
Herein, we present the formation of nanoreactors that combine
the unique structural elements of copolymeric colloidal stomato-
cytes with the functional elements of CLEAs, displaying the
potential of such robust catalytic systems, for the rst time, in
a ow reactor. Our strategy to achieving this is based on the utility
of the stomach of poly(ethylene glycol)-polystyrene (PEG-PS) sto-
matocytes for in situ formation of compartmentalized cross-linked
enzyme nano-aggregates (c-CLEnA) (Fig. 1). Remarkably, the
amount of cross-linkers needed was much less compared to the
macroscopic CLEA process, which resulted in a much betterFig. 1 (Top) Formation of compartmentalized-cross-linked enzyme
nano-aggregates (c-CLEnA) via cross-linker addition (either glutaral-
dehyde or genipin). (Bottom) c-CLEnA application and reuse for in-
ﬂow catalysis.
Chem. Sci.preservation of catalytic activity. We rst demonstrated the feasi-
bility of the c-CLEnA process using the lipase Candida antarctica
Lipase B (CalB). Indeed, upon formation of the CalB c-CLEnA
nanoreactors the PEG-PS stomatocytes retained their structural
integrity and demonstrated enzymatic activity similar to the free
enzyme. To demonstrate the generality of this approach, we
repeated the process to generate c-CLEnAs with diﬀerent enzymes,
including porcine liver esterase (PLE) and an enzymatic cascade
involving glucose oxidase (GOx) and horse radish peroxidase
(HRP). Importantly, reactions using the c-CLEnA nanoreactors
were successfully implemented in a ow reactor where there was
no apparent loss of activity, even aer ten cycles.
Results and discussions
Recently, we presented a robust platform for the compartmen-
talization of enzymes in bowl-shaped stomatocyte nano-
particles.18,22 Such stomatocytes were formed through osmotic-
induced shape transformation of spherical polymer vesicles
(polymersomes) that were comprised of poly(ethylene glycol)-
block-poly(styrene) (PEG-PS) copolymers. Stomatocytes are able
to encapsulate one, or more enzymatic species within their
inner compartment, with relatively high encapsulation eﬃ-
ciency ranging from 8 to 35%, dependent on the initial feed and
the enzyme properties. The high local concentration of catalyst
and the easy accessibility of the substrate toward the cavity,
makes stomatocytes an interesting tool in catalytic aqueous
processes. In our present strategy, we utilized PEG-PS stoma-
tocytes to entrap proteins, which were subsequently turned into
cross-linked enzyme nano-aggregates (CLEnA) under the action
of glutaraldehyde (Fig. 2A) or genipin.
In the rst instance, glutaraldehyde was used to validate our
ability to cross-link enzymes insides the cavity of the stomatocytes.
To this end, formation of c-CLEnAwas initiated by encapsulation ofFig. 2 Transmission electron microscopy (TEM) images of (A and B)
CalB loaded stomatocytes with narrow neck. (C and D) Stomatocytes
compartmentalizing cross-linked CalB; CalB c-CLEnA. Scale bars
correspond to 200 nm.
This journal is © The Royal Society of Chemistry 2020
Fig. 3 (A) Activity of PLE c-CLEnA formed at diﬀerent concentrations
of glutaraldehyde. An increase in activity is observed when glutaral-
dehyde concentrations are decreased. The absorbance of the product
is measured at 405 nm at diﬀerent concentration of p-NPA. (B) Activity
of GOx/HRP c-CLEnA formed at diﬀerent concentrations of glutaral-
dehyde. Resoruﬁn formation is measured at a (D)-glucose concen-
tration of 20 mM. Please note the diﬀerence in enzymatic activity of
both PLE and GOx/HRP when glutaraldehyde (A and B) and genipin (C
and D) were used for c-CLEnA formation.
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View Article Onlinethe 34 kDa lipase CalB within PEG-PS stomatocytes under relatively
mild conditions, whereby CalB (12 mg mL1) was added to open
neck stomatocytes (0.5 mL, 10 mg mL1), and the enzyme was
encapsulated in the stomatocytes' cavity by narrowing the neck via
a shape change process induced by a small aliquot of organic
solvent and subsequent washing with salt solution (Fig. S1 and
S2†).18,22 Aerwards, stomatocytes were dispersed in phosphate-
buﬀered saline (PBS), and glutaraldehyde (0.1 mL, 150 mM) was
slowly added. Employing this CLEA-based enzyme cross-linking
strategy, in which lysine residues are chemically bonded, tem-
plated formation of CLEnA was performed in the stomach of the
PEG-PS stomatocytes. The resulting c-CLEnAs maintained their
unique morphological characteristics (Fig. 2B) with increasing
internal density (due to CLEnA formation). This was also
conrmed via analysis of the shape factor, r (the ratio between
radius of gyration, Rg, and hydrodynamic radius, Rh), where the r
value of stomatocytes compartmentalizing CalB CLEnAwas ca. 0.73
(Fig. S3†), indicative of the formation of a solid sphere.22,23 In order
to characterize the nature of the CLEnA formed during this
process, stomatocytes were unloaded via adding an excess of
organic solvent, which dissolved the polymer shell so that the
templated CalB particles could be characterized. Dynamic Light
Scattering (Fig. S4†) analysis showed formation of CLEnA particles
of ca. 45 nm. This size was larger than the neck size of the PEG-PS
stomatocytes (ca. 5 nm, Fig. 2A), ensuring better entrapment than
the free CalB enzymes. Furthermore, from SDS-PAGE gel analysis it
was evident that no monomeric enzyme existed (Fig. S5†), as only
a high molecular weight species was observed, which showed that
the cross-linking process proceeded with high eﬃciency. When
CalB was free in solution, similar conditions of cross-linking led to
formation of CLEAs, however, with less control over the size of the
structures and a broad size distribution ranging from10 to 100 mm,
as conrmed by scanning electron microscopy (Fig. S6†).
To demonstrate the ability of the formed c-CLEnA to function
as catalytic system we measured the activity of the CalB-mediated
hydrolysis of p-nitrophenyl acetate (pNPA). The activity of c-CLEnA
was superior to that of the free enzyme or the encapsulated CalB
into stomatocytes prior to cross-linking (Fig. S7†). Although this
seems remarkable, as activity is normally diminished due to
cross-linking with glutaraldehyde, CalB is a known exception to
this rule.24,25 In order to conrm the generality of our method-
ology, we set out to cross-link a diﬀerent enzyme, PLE, employing
the same conditions as for CalB (0.1 mL of 150 mM of glutaral-
dehyde, ESI† 2.3 and 2.4). However, these initial conditions had
a strong negative impact on PLE activity (Fig. S8A†). Through
careful tuning of the amount of glutaraldehyde employed, we
were able to induce the formation of PLE c-CLEnAs under milder
conditions by using 50 mM of glutaraldehyde instead of 150 mM.
These milder conditions of cross-linking led to a higher VMAX
(Fig. 3A and S8B†). It is worth to mention that 50 mM glutaral-
dehyde was not enough to cross-link PLE present in a free enzyme
solution when the same ratio enzyme/glutaraldehyde was used
and even the addition of 75 mM and 100 mM of glutaraldehyde
led only to partial cross-linking of the free enzyme (Fig. S9†). This
highlights the advantageous eﬀect of enzyme compartmentali-
zation as it increases the enzyme local concentration and facili-
tates the cross-linking process. Since genipin is known to beThis journal is © The Royal Society of Chemistry 2020a milder cross-linker and is widely used in applications in
medicine and food technology,26–28 we set out to cross-link
PLE using genipin instead of glutaraldehyde – aiming at
fully preserving its activity. Gratifyingly, when genipin was used
(30–50 mM), the activity of PLE c-CLEnA was maintained and no
decrease of enzyme activity was observed (Fig. S8C and D†).
Notably, the addition of 30 mM of genipin has a positive impact
on the activity (Fig. 3C and S8D†). Besides, the aspect of the PLE
nano-aggregates and the shape of the stomatocyte nanoreactor
was not aﬀected by genipin (Fig. S10 and S18†). Furthermore, to
demonstrate that this method is not restricted to single enzyme
systems we generated a dual enzyme c-CLEnA where glucose
oxidase (GOx) and horseradish peroxidase (HRP) were co-
encapsulated in stomatocytes prior to cross-linking. The pres-
ence of both enzymes within the stomatocyte was conrmed by
SDS-PAGE (Fig. S11†). Again, cross-linking inside the stomato-
cytes proved to be a more eﬃcient process than cross-linking of
a free enzyme solution at same concentrations. The activity of the
dual-functional c-CLEnA was conrmed with the peroxidation of
Amplex Red, and compared with the activity of stomatocytes
loaded with uncross-linked GOx/HRP and with the free enzymes
(Fig. S12†). Similarly to the case of PLE, the activity was depen-
dent on the concentration of cross-linker, and when using 30mM
of glutaraldehyde the native activity was preserved (Fig. 3B and
S12A†). Again, when genipin was used as cross-linker the native
activity of GOx/HRP was not aﬀected (Fig. S12B†).Chem. Sci.
Chemical Science Edge Article
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View Article OnlineFinally, the performance of CalB c-CLEnA was evaluated in
a ow setup. We rst set out to optimize the enzyme loading for
maximum eﬃciency in-ow. Three diﬀerent enzyme feeds were
added to diﬀerent stomatocyte batches prior to the encapsulation
process. When 12 mg mL1 of CalB was initially added, an
encapsulation eﬃciency of 14% of the initial feed was reached,
whilst 33% and 8% were achieved when 16 mg mL1 and 6 mg
mL1 were added, proving that a good control over the loading
eﬃciency could be achieved by simply varying the initial enzyme
concentration. We next set out to test the capacity of stomatocytes
in-ow. CalB loaded stomatocytes and CalB c-CLEnA (with 33%,
14% and 8% encapsulation eﬃciency) were immobilized into
a ow reactor (Fig. S13†), equipped with an internal membrane to
retain the polymeric vesicles. Catalytic tests were performed aer
which the stomatocytes or the c-CLEnA were recollected from the
membrane outlet, and washed by spin ltration before the next
catalytic cycle (ESI 2.9†). When the diﬀerent non-cross-linked CalB
loaded stomatocytes were fed in the ow reactor, aer the rst
catalytic run (13 min, 0.3 mL min1), a clear loss in activity was
observed (Fig. S14†). This loss in activity was most severe with the
8% loaded stomatocytes, which only retained approximately 60%of
the initial catalytic eﬃciency, aer the second run. A clear loss in
activity was observed in all non-crosslinked stomatocyte samples
over the course of 5 runs of the ow experiments (Fig. 4A and S14†).
It was evident that the loss of activity was related to signicant
leaching of the enzyme during the reaction. Due to the small size of
the protein, the entrapped enzyme was partially ushed away from
the stomatocytes' cavity due to the washing and reloading process
(ESI 2.9†). In contrast, when in the same process c-CLEnA was
employed, no loss in activity, over the course of ve runs, wasFig. 4 (A) Comparison between the relative activity of CalB loaded
stomatocytes (with non-cross-linked CalB) and CalB c-CLEnA (both
with 33% encapsulation eﬃciency) during ﬁve runs in-ﬂow. (B) Relative
activity of CalB c-CLEnA (with 33% encapsulation eﬃciency) during ten
runs in-ﬂow. (C) Comparison between the relative activity of PLE
loaded stomatocytes (with non-cross-linked PLE) and PLE c-CLEnA
(both with 21% encapsulation eﬃciency) during ﬁve runs in-ﬂow. (D)
Relative activity of PLE c-CLEnA (with 21% encapsulation eﬃciency)
during ten runs in-ﬂow.
Chem. Sci.observed (Fig. 4A). Even when CalB c-CLEnA were reused in-ow for
ten reaction runs in ow, still no leaching or loss in activity was
detected (Fig. 4B), conrming their potential for continuous ow
applications. Moreover, aer ten runs in ow (ow rate 0.6
mL min1) there was no apparent change in particle morphology,
with fully intact stomatocytes being observed by scanning electron
microscopy (SEM) (Fig. S15†). Due to the strong negative eﬀect of
glutaraldehyde on PLE enzyme, PLE c-CLEnA was formed
using genipin for all studies in-ow (Fig. 4C and D). Similar to CalB
c-CLEnA, PLE c-CLEnA was recycled for ten runs in ow, however,
ca. 20% decrease in activity was observed. In comparison to PLE
loaded stomatocytes, the decrease in activity of PLE c-CLEnA is not
remarkable. Such loss of activity can be attributed to the highly
sensitive nature of PLE. Another plausible reason is due to themild
cross-linking eﬀect of genipin, which might lead to the presence of
small fraction of non-cross-linked PLE. Aer several cycles, such
non cross-linked PLE would be able to escape the stomatocyte,
leading to this decrease in activity. That notwithstanding, this
experiment is a direct proof of the applicability of our approach
toward more sensitive enzymes – a promising platform for enzy-
matic catalysis in-ow.
Conclusions
In summary, we have shown a novel and robust methodology to
construct nano-sized cross-linked enzyme aggregates (c-CLEnA)
via their templated formation in the cavity of bowl-shaped
polymeric compartments, or stomatocytes. The preorganiza-
tion of enzymes in the stomatocyte cavity resulted in a high local
concentration, which therefore required a substantially smaller
amount of cross-linking agent to obtain stable cross-linked
systems. In comparison to previously reported CLEA
approaches, our c-CLEnA combines the benecial aspects of
a cross-linked enzyme system with the well-dened nanometer
sized dimensions of the nanoreactors. The milder cross-linking
conditions enabled a better preservation of enzyme activity,
proving the general advantages of our method for applications
in biocatalysis. Our cross-linking methodology worked equally
well for single enzymes and enzymemixtures. The robustness of
the c-CLEnA systems was tested in a micro-reactor ow set-up,
in which the c-CLEnA could be reused for ten times without
losing any activity, in clear contrast to the controls. This
conceptually new approach allows the mild cross-linking of
enzymes into well-dened nano-sized particles, which can nd
their application in ow chemistry and other processes in which
catalytic nano-aggregates are benecial.
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